Ohtani H, Strauss H W, Southern J F, Tamatani T, Miyasaka M, Sekiguchi M, Isobe M
First Department of Internal Medicine, Fukushima Medical College, Japan.
J Am Coll Cardiol. 1995 Sep;26(3):793-9. doi: 10.1016/0735-1097(95)00222-P.
Rats with abdominal heterotopic heart transplants were studied to determine whether cardiac allograft rejection could be assessed by immunoscintigraphy targeting intercellular adhesion molecule-1 (ICAM-1), which was induced on allografted organ cells in association with rejection.
It is important to detect early rejection before development of myocyte necrosis. Although a variety of methods for the detection of cardiac rejection have been investigated, histologic inspection of biopsied samples is still used routinely for clinical diagnosis of rejection.
DA rat (RT-1a) hearts were transplanted into PVG rats (RT-1c). Immunohistologic examination of the allografts demonstrated that ICAM-1 induction on vascular endothelial cells was observed as early as 4 days after transplantation in this combination. Thirty-nine allografted rats and seven isografted rats were studied. One day after injection of 100 microCi of 111Inlabeled anti-ICAM-1 monoclonal antibody (1A29), planar images were obtained.
Rejecting allografts showed increased radiotracer uptake and could be identified on the images as early as 5 days after transplantation. In contrast, nonrejecting cardiac allografts and isografts did not show specific uptake. Mildly rejecting allografts, with mononuclear cell infiltration but without significant myocyte necrosis, could be scintigraphically identified, and the level of radiotracer uptake reflected the histologic severity of rejection. Accumulation of 111In-labeled monoclonal antibody of isotype-matched irrelevant specificity was not detected in the rejecting allografts.
These data indicate that ICAM-1 induction can be assessed quantitatively by radioimmunoscintigraphy. Radioimmunoscitigraphy is a sensitive method for early detection and assessment of cardiac allograft rejection.
对进行腹部异位心脏移植的大鼠进行研究,以确定是否可通过靶向细胞间黏附分子-1(ICAM-1)的免疫闪烁显像来评估心脏同种异体移植排斥反应,ICAM-1是在同种异体移植器官细胞上伴随排斥反应而诱导产生的。
在心肌细胞坏死发生之前检测早期排斥反应很重要。尽管已经研究了多种检测心脏排斥反应的方法,但活检样本的组织学检查仍常规用于排斥反应的临床诊断。
将DA大鼠(RT-1a)的心脏移植到PVG大鼠(RT-1c)体内。对同种异体移植物的免疫组织学检查表明,在这种组合中,移植后4天即可观察到血管内皮细胞上ICAM-1的诱导。研究了39只同种异体移植大鼠和7只同基因移植大鼠。注射100微居里的111铟标记抗ICAM-1单克隆抗体(1A29)1天后,获取平面图像。
发生排斥反应的同种异体移植物显示放射性示踪剂摄取增加,并且在移植后5天即可在图像上识别出来。相比之下,未发生排斥反应的心脏同种异体移植物和同基因移植物未显示出特异性摄取。轻度排斥的同种异体移植物有单核细胞浸润但无明显的心肌细胞坏死,可通过闪烁显像识别出来,放射性示踪剂摄取水平反映了排斥反应的组织学严重程度。在发生排斥反应的同种异体移植物中未检测到同型匹配的无关特异性111铟标记单克隆抗体的蓄积。
这些数据表明,ICAM-1的诱导可通过放射免疫闪烁显像进行定量评估。放射免疫闪烁显像是早期检测和评估心脏同种异体移植排斥反应的一种敏感方法。